Sonic hedgehog participates in craniofacial morphogenesis and is down-regulated by teratogenic doses of retinoic acid.
The face is one of the most intricately patterned structures in human and yet little is known of the mechanisms by which the tissues are instructed to grow, fuse, and differentiate. We undertook a study to determine if the craniofacial primordia used the same molecular cues that mediate growth and patterning in other embryonic tissues such as the neural tube and the limb. Here we provide evidence for the presence of organizer-like tissues in the craniofacial primordia. These candidate organizers express the polarizing signal sonic hedghog (shh) and its putative receptor, patched, as well as fibroblast growth factor 8 and bone morphogeneic protein 2. Shh-expressing epithelial grafts functioned as organizing tissues in a limb bud assay system, where they evoked duplications of the digit pattern. High doses of retinoic acid, which are known to truncate the growth of the frontonasal and maxillary processes and thus produce bilateral clefting of the lip and palate, inhibited the expression of shh and patched but not fgf8, in the craniofacial primordia, and abolished polarizing activity of these tissues. From these studies we conclude that the embryonic face contains signaling centers in the epithelium that participate in craniofacial growth and patterning. In addition, we discuss a novel mechanism whereby retinoids can exert a teratogenic effect on craniofacial morphogenesis independent of its effects on Hox gene expression or neural crest cell migration.
Helms
J A
JA
Department of Orthopaedic Surgery, University of California at San Francisco, 94143, USA. helms@cgl.ucsf.edu
Kim
C H
CH
Hu
D
D
Minkoff
R
R
Thaller
C
C
Eichele
G
G
D000818:Animals; D002642:Chick Embryo; D002971:Cleft Lip; D002972:Cleft Palate; D019465:Craniofacial Abnormalities / Q000139:chemically induced / Q000196:embryology*; D004475:Ectoderm / Q000166:cytology / Q000502:physiology; D004627:Embryonic Induction; D004707:Endoderm / Q000166:cytology / Q000502:physiology*; D004848:Epithelium / Q000196:embryology / Q000502:physiology; D005145:Face / Q000196:embryology; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects*; D053823:Hedgehog Proteins; D006801:Humans; D018878:Limb Buds / Q000187:drug effects; D008437:Maxilla / Q000196:embryology; D009024:Morphogenesis / Q000187:drug effects / Q000502:physiology*; D014176:Protein Biosynthesis; D011506:Proteins / Q000502:physiology*; D012886:Skull / Q000196:embryology; D013723:Teratogens / Q000633:toxicity*; D015534:Trans-Activators; D014158:Transcription, Genetic; D014212:Tretinoin / Q000633:toxicity*
D053823:Hedgehog Proteins; D011506:Proteins; C509239:SHH protein, human; D013723:Teratogens; D015534:Trans-Activators; D014212:Tretinoin